View Older Stories View More Recent Stories

Apr 2, 2019 07:30AM Novocure to Report First Quarter 2019 Financial Results
Mar 22, 2019 07:30AM Novocure (NVCR) Commences Phase 3 Pivotal Trial in Recurrent Ovarian Cancer
Mar 22, 2019 07:30AM Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer
Mar 21, 2019 07:30AM Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019
Mar 21, 2019 06:30AM Novocure’s Chief Science Officer Retires after 17 Years of Service
Mar 18, 2019 07:30AM Novocure to Participate in Oppenheimer’s 29th Annual Healthcare Conference
Feb 28, 2019 06:00AM Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
Jan 7, 2019 04:08PM Novocure (NVCR) Announces Q4 Operating Statistics, Preliminary Net Revenues
Jan 7, 2019 04:05PM Novocure Announces Fourth Quarter and Full Year 2018 Operating Statistics, Preliminary Net Revenues and Provides Company Update
Dec 21, 2018 07:30AM Novocure to Participate in the 37th Annual J.P. Morgan Healthcare Conference
Dec 17, 2018 07:30AM Novocure and the AACR Announce Four Inaugural Research Grants to Promote and Support Innovative Research on Tumor Treating Fields
Dec 6, 2018 07:34AM Novocure (NVCR) Says Sub-Group Analysis of EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology
Dec 6, 2018 07:30AM Sub-Group Analysis of Novocure’s EF-14 Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Published in Journal of Neuro-Oncology Demonstrating More Time on Optune® Predicted Increased Survival
Nov 14, 2018 07:30AM Zai Lab and Novocure Awarded Deal of the Year
Nov 14, 2018 07:30AM Novocure and Zai Lab Awarded Deal of the Year at 5th Annual BioCentury China Healthcare Summit in Shanghai, China
Nov 14, 2018 07:30AM Zai Lab and Novocure Awarded Deal of the Year
Nov 13, 2018 08:24AM Novocure Announces More than 70 Presentations on Tumor Treating Fields at 23rd Annual Meeting of the Society for Neuro-Oncology
Nov 7, 2018 04:00PM Novocure and Zai Lab to Host Investor Event
Oct 25, 2018 06:00AM Novocure Reports Third Quarter 2018 Financial Results and Provides Company Update
Oct 24, 2018 04:58PM Novocure (NVCR) Announces Retirement of Founder Yoram Palti, MD, PhD and Louis J. Lavigne, Jr. from Board
Oct 24, 2018 04:00PM Novocure Founder Professor Yoram Palti and Director Louis J. Lavigne, Jr. Retire from Board of Directors
Oct 23, 2018 05:57PM Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma
Oct 22, 2018 07:32AM Novocure (NVCR) Reports Results of PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields
Oct 22, 2018 07:30AM Pancreatology Publishes Results of the PANOVA Phase 2 Pilot Trial in Advanced Pancreatic Cancer Suggesting Improved Survival of Patients Treated with Tumor Treating Fields
Oct 18, 2018 07:36AM Novocure (NVCR) Says Medicare DME MACs Have Accepted Local Coverage Determination Reconsideration Request for Optune
Oct 18, 2018 07:30AM Novocure Announces that the Medicare DME MACs Have Accepted the Local Coverage Determination Reconsideration Request for Optune®
Oct 4, 2018 09:08AM Novocure Announces 55 Presentations at European Association of Neuro-Oncology Meeting 2018
Oct 1, 2018 08:36AM Novocure to Report Third Quarter 2018 Financial Results
Sep 25, 2018 07:30AM Data from STELLAR Registration Trial of Tumor Treating Fields in Mesothelioma to be Presented at the IASLC 19th World Conference on Lung Cancer
Sep 12, 2018 07:34AM Novocure (NVCR), Zai Lab (ZLAB) Announce Strategic Collaboration with License Agreement for Tumor Treating Fields in Greater China
Sep 12, 2018 07:30AM Novocure and Zai Lab Announce Strategic Collaboration with a License Agreement for Tumor Treating Fields in Greater China
Sep 5, 2018 05:08PM Novocure (NVCR) Reports Final Results from STELLAR Phase 2 Registration Trial in Mesothelioma, Demonstrating 'Significant Extension in Median Overall Survival'
Sep 5, 2018 05:00PM Tumor Treating Fields Plus Standard of Care Chemotherapy Significantly Extends Median Overall Survival by 6.1 Months in STELLAR Phase 2 Registration Trial in Mesothelioma Compared to Historical Contro
Aug 15, 2018 07:34AM Novocure (NVCR), US Oncology Research Announce Collaboration on PANOVA-3 Trial
Aug 15, 2018 07:30AM Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
Aug 3, 2018 07:30AM Novocure to Present at Two Upcoming Investor Conferences
Aug 2, 2018 09:24AM Novocure (NVCR) Names Jeryl Hilleman to Board
Aug 2, 2018 07:30AM Novocure Announces Addition to Its Board of Directors
Jul 31, 2018 07:34AM Novocure (NVCR) Says Gynecologic Oncology Published Results of INNOVATE Phase 2 Pilot Study
Jul 31, 2018 07:30AM Gynecologic Oncology Publishes Results of the INNOVATE Phase 2 Pilot Study Demonstrating Combination of Tumor Treating Fields with Paclitaxel May Improve Survival of Patients with Recurrent Ovarian Ca
Jul 26, 2018 06:00AM Novocure Reports Second Quarter 2018 Financial Results and Provides Company Update
Jul 19, 2018 07:30AM Novocure Announces 13 Presentations at American Society for Radiation Oncology 2018 Annual Meeting
Jul 17, 2018 07:30AM Scientific Track Dedicated to Tumor Treating Fields at 40th International Conference of the IEEE Engineering in Medicine and Biology Society
Jul 2, 2018 08:00AM Novocure Appoints Pritesh Shah as Chief Commercial Officer
Jul 2, 2018 07:30AM Novocure to Report Second Quarter 2018 Financial Results
Jun 4, 2018 07:35AM Novocure (NVCR) to Present INNOVATE-3 Phase 3 Pivotal Trial Design in Recurrent Ovarian Cancer at ASCO
Jun 4, 2018 07:30AM Novocure to Present INNOVATE-3 Phase 3 Pivotal Trial Design in Recurrent Ovarian Cancer at the American Society of Clinical Oncology Annual Meeting 2018
May 31, 2018 04:05PM Novocure Announces Changes to Its Board of Directors
Apr 26, 2018 06:00AM Novocure Reports First Quarter 2018 Financial Results and Provides Company Update
Apr 17, 2018 07:31AM Novocure (NVCR) Announces Positive Top-line Results from STELLAR Phase 2 Pilot Trial in Mesothelioma
View More Recent Stories View Older Stories